fclitloan

Peptide Therapeutics: Contract API manufacturing market is estimated to be worth USD 3.2 billion in 2030, predicts Roots Analysis

Given the growing demand for peptide drugs and the complexities associated with their development and production, relying on the superior technical expertise and experience of CMOs / CDMOs is presently a widely accepted business model

Roots Analysis is pleased to announce the publication of its recent study, titled, “”

The “Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030” report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of therapeutic peptides. The study also features a detailed analysis of key drivers and trends related to this evolving domain. Amongst other elements, the report includes:

A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

Scale of Operation

Type of Peptide Synthesis Method Used

Type of Peptide Chemical Synthesis Method Used

Type of End User

Key Geographical Region

Transcripts of survey held with the following senior level representatives of stakeholder companies

Key companies covered in the report

Flaoji.orgor more information, please click on the following link:

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

About Roots Analysis

is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com